EGFR and neoplasm: LAMC2, a target gene of miR-134, activates the EGFR/MAPK pathway but is also downregulated by miR-134, thereby inhibiting the migration and invasion of OSCC tumour stem cells by suppressing the PI3K-Akt signalling pathway [42].